Pay-per-use imaging provider medneo will enter London's healthcare market in Q4 this year with a centre in Harley Street. We catch up with co-founder Nicolas Weber.
UK-based telehealth provider Babylon is now Europe's largest digital health company after new investors committed $550m in a Series C round, signalling a partnership with one of America's largest healthcare companies, Centene, is on the cards.
In a lot of Western European countries, especially where there is a national health service funded by taxation, for-profit healthcare providers are seen at best as a necessary evil by government. Or at least, that is what they would have you believe.
As first reported by HBI, dialysis group Diaverum looks certain to be sold by Bridgepoint. Reuters now suggests that Diaverum is "exploring" and "testing the appetite" for a €2bn sale of the global dialysis group Diaverum. We go through potential buyers.
Ophthalmology operators look set to pay the price of a new EU regulation. The European Device Regulation comes into force in May next year, and medtech suppliers are likely to pass the additional costs this places onto them on.
HBI talks to Tim Clover, CEO of ophthalmology medtech supplier Rayner and former CEO of ophthalmology operator Optegra about his take on the market, challenges and opportunities in the future, and plans for the company going forward, including coming to market in the next two years - or sooner.
UK nursing home provider Four Seasons, one of a number of care home assets failing to sell in the UK, is beginning to attract bidders within a £400-600m price band. We discuss pricing, bidders, multiples and views on the market.
For the first time in years, a US-based patient-facing digital healthcare company will IPO. Will this encourage similar companies in Europe to go public? HBI assesses.
There are strong rumours that UK dialysis provider Renal Services will be put up for sale in the next 12 months. CEO and majority shareholder Stefano Ciampolini tells HBI that while there is no process or mandate at the moment, the group is mulling its options.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
